News

Aiosyn is awarded the NWO Take Off Phase II grant

Aiosyn, a Radboudumc spin-off company that develops AI-powered pathology algorithms for clinical diagnostics and life sciences, was awarded early-phase funding of Eur 250.000 by NWO (Dutch Research Council).

ATRO Medical closes a new financing round for the Trammpolin® meniscus prosthesis

ATRO Medical announces the successful closure of a €1.9 million financing round to complete the AIR2 clinical study.

T-Guard can reset immune system

For 20 years, the Nijmegen based Radboudumc spin-off company Xenikos has been working on a drug that can reset the immune system. This reset will save lives of seriously ill patients. Now, after years of hard work, the moment of truth has arrived for T-guard.

Thomas van den Heuvel wins Stairway to Impact Award for safer pregnancies using AI Award for safer pregnancies using AI

Radboudumc researcher Thomas van den Heuvel receives the Stairway to Impact Award from Dutch Research Council NWO. He receives this prize for the development of the BabyChecker, a smartphone application that allows midwives to make ultrasounds during pregnancies.

Radboud university medical center accelerates medical imaging innovation with AWS Cloud